Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2015 2
2016 2
2017 7
2018 4
2019 2
2020 2
2021 4
2022 10
2023 5
2024 11
2025 11
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
The clinical outcomes of combined stereotactic radiosurgery with PD-1/PD-L1 inhibitors in patients with metastatic brain tumors: a systematic review and meta-analysis on the safety and efficacy.
Ahmadvand MH, Habibi MA, Mirjani MS, Bahri A, Aghaei F, Foroughi A, Ghazizadeh Y, Shahir Eftekhar M, Gandomkar H, Delbari P, Mohammadzadeh I, Hajikarimloo B, Tos SM, Shafizadeh M, Sheehan JP. Ahmadvand MH, et al. Among authors: aghaei f. Neurosurg Rev. 2025 Nov 3;48(1):756. doi: 10.1007/s10143-025-03909-z. Neurosurg Rev. 2025. PMID: 41182419
Effects of six-month home-based neuro-functional and resistance training interventions on cognitive and motor performance in multiple sclerosis patients with cognitive impairment: A randomized controlled trial.
Ghahfarrokhi MM, Aghaei F, Fallahi S, Banitalebi E, Faramarzi M, Parastesh M, Motl RW. Ghahfarrokhi MM, et al. Among authors: aghaei f. Mult Scler Relat Disord. 2025 Nov;103:106725. doi: 10.1016/j.msard.2025.106725. Epub 2025 Sep 4. Mult Scler Relat Disord. 2025. PMID: 40946696 Clinical Trial.
The safety and efficacy of dabrafenib plus trametinib for patients with brain metastatic melanoma: a systematic review and meta-analysis.
Habibi MA, Mirjani MS, Hajikarimloo B, Dashti M, Ghasemzadeh A, Hojjat SH, Eftekhar MS, Doraghi K, Ghazizadeh Y, Aghaei F, Karami S, Edalat M, Rashidi F, Ahmadpour S, Ahmadi S. Habibi MA, et al. Among authors: aghaei f. Discov Oncol. 2025 Jun 3;16(1):996. doi: 10.1007/s12672-025-02778-8. Discov Oncol. 2025. PMID: 40461758 Free PMC article.
58 results